MedTrace Logo

Effects of Low Concentration Atropine on Pupillary Size and Accommodative Amplitude

NCT03699423 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2018-10-09

No results posted yet for this study

Summary

To assess the two-week ocular responses, especially on pupillary size and accommodative amplitude, of nightly application of 0.01% or 0.02% or 0.03% atropine eye drops in children with myopia who were randomized to use of three different low-concentration atropine eye drops

Conditions

  • Myopia

Interventions

DRUG

0.01% atropine eye drops

0.01% atropine sulphate

DRUG

0.02% atropine eye drops

0.02% atropine sulphate

DRUG

0.03% atropine eye drops

0.03% atropine sulphate

Sponsors & Collaborators

  • Brien Holden Vision

    collaborator INDUSTRY

  • Hai Yen Eye Care

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-08
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03699423 on ClinicalTrials.gov